BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37832906)

  • 21. The clinical value of optical genome mapping in the rapid characterization of RB1 duplication and 15q23q24.2 triplication, for more appropriate prenatal genetic counselling.
    Bouassida M; Molina-Gomes D; Koraichi F; Hervé B; Lhuilier M; Duvillier C; Le Gall J; Gauthier-Villars M; Serazin V; Quibel T; Dard R; Vialard F
    Mol Genet Genomic Med; 2024 Apr; 12(4):e2437. PubMed ID: 38588252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optical Genome Mapping in Routine Human Genetic Diagnostics-Its Advantages and Limitations.
    Dremsek P; Schwarz T; Weil B; Malashka A; Laccone F; Neesen J
    Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical Genome Mapping Reveals and Characterizes Recurrent Aberrations and New Fusion Genes in Adult ALL.
    Vieler LM; Nilius-Eliliwi V; Schroers R; Vangala DB; Nguyen HP; Gerding WM
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Optical genome mapping analysis of a Chinese pedigree with a rare chromosome 17 paracentric inversion insertion].
    Wang H; Yang Y; Yang N; Wang Y; Li H; Hu W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Jun; 40(6):727-732. PubMed ID: 37212011
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of complex and cryptic chromosomal rearrangements by optical genome mapping.
    Shi S; Huang P; Yan R; Li R
    Mol Cytogenet; 2023 Apr; 16(1):5. PubMed ID: 37101225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optical genome mapping reveals additional prognostic information compared to conventional cytogenetics in AML/MDS patients.
    Gerding WM; Tembrink M; Nilius-Eliliwi V; Mika T; Dimopoulos F; Ladigan-Badura S; Eckhardt M; Pohl M; Wünnenberg M; Farshi P; Reimer P; Schroers R; Nguyen HP; Vangala DB
    Int J Cancer; 2022 Jun; 150(12):1998-2011. PubMed ID: 35064925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal detection of Down's syndrome by rapid aneuploidy testing for chromosomes 13, 18, and 21 by FISH or PCR without a full karyotype: a cytogenetic risk assessment.
    Caine A; Maltby AE; Parkin CA; Waters JJ; Crolla JA;
    Lancet; 2005 Jul 9-15; 366(9480):123-8. PubMed ID: 16005334
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optical Genome Mapping as an Alternative to FISH-Based Cytogenetic Assessment in Chronic Lymphocytic Leukemia.
    Valkama A; Vorimo S; Kumpula TA; Räsänen H; Savolainen ER; Pylkäs K; Mantere T
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Validation and Diagnostic Utility of Optical Genome Mapping for Enhanced Cytogenomic Analysis of Hematological Neoplasms.
    Sahajpal NS; Mondal AK; Tvrdik T; Hauenstein J; Shi H; Deeb KK; Saxe D; Hastie AR; Chaubey A; Savage NM; Kota V; Kolhe R
    J Mol Diagn; 2022 Dec; 24(12):1279-1291. PubMed ID: 36265723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.
    Lestringant V; Duployez N; Penther D; Luquet I; Derrieux C; Lutun A; Preudhomme C; West M; Ouled-Haddou H; Devoldere C; Marolleau JP; Garçon L; Jedraszak G; Ferret Y
    Genes Chromosomes Cancer; 2021 Oct; 60(10):657-667. PubMed ID: 33982372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optical Genome Mapping: Integrating Structural Variations for Precise Homologous Recombination Deficiency Score Calculation.
    Sahajpal NS; Mondal AK; Vashisht A; Singh H; Pang AWC; Saul D; Nivin O; Hilton B; DuPont BR; Kota V; Savage NM; Hastie AR; Chaubey A; Kolhe R
    Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective chromosome analysis of 3429 amniocentesis samples in China using copy number variation sequencing.
    Wang J; Chen L; Zhou C; Wang L; Xie H; Xiao Y; Zhu H; Hu T; Zhang Z; Zhu Q; Liu Z; Liu S; Wang H; Xu M; Ren Z; Yu F; Cram DS; Liu H
    Am J Obstet Gynecol; 2018 Sep; 219(3):287.e1-287.e18. PubMed ID: 29852155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optical Genome Mapping for a Patient with a Congenital Disorder and Chromosomal Translocation.
    Ogiwara Y; Hattori A; Ikegawa K; Hasegawa Y; Kuroki Y; Miyado M; Fukami M
    Cytogenet Genome Res; 2022; 162(11-12):617-624. PubMed ID: 37231804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fetal hydrops and the Incremental yield of Next-generation sequencing over standard prenatal Diagnostic testing (FIND) study: prospective cohort study and meta-analysis.
    Mone F; Eberhardt RY; Hurles ME; Mcmullan DJ; Maher ER; Lord J; Chitty LS; Dempsey E; Homfray T; Giordano JL; Wapner RJ; Sun L; Sparks TN; Norton ME; Kilby MD
    Ultrasound Obstet Gynecol; 2021 Oct; 58(4):509-518. PubMed ID: 33847422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimizing the diagnostic workflow for acute lymphoblastic leukemia by optical genome mapping.
    Rack K; De Bie J; Ameye G; Gielen O; Demeyer S; Cools J; De Keersmaecker K; Vermeesch JR; Maertens J; Segers H; Michaux L; Dewaele B
    Am J Hematol; 2022 May; 97(5):548-561. PubMed ID: 35119131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytogenetic Assessment and Risk Stratification in Myelofibrosis with Optical Genome Mapping.
    Díaz-González Á; Mora E; Avetisyan G; Furió S; De la Puerta R; Gil JV; Liquori A; Villamón E; García-Hernández C; Santiago M; García-Ruiz C; Llop M; Ferrer-Lores B; Barragán E; García-Palomares S; Mayordomo E; Luna I; Vicente A; Cordón L; Senent L; Álvarez-Larrán A; Cervera J; De la Rubia J; Hernández-Boluda JC; Such E
    Cancers (Basel); 2023 Jun; 15(11):. PubMed ID: 37297002
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Optical Genome Mapping With Conventional Diagnostic Methods for Structural Variant Detection in Hematologic Malignancies.
    Shim Y; Koo YK; Shin S; Lee ST; Lee KA; Choi JR
    Ann Lab Med; 2024 Jul; 44(4):324-334. PubMed ID: 38433573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optical Genome Mapping for Comprehensive Cytogenetic Analysis of Soft-Tissue and Bone Tumors for Diagnostic Purposes.
    Baelen J; Dewaele B; Debiec-Rychter M; Sciot R; Schöffski P; Hompes D; Sinnaeve F; Wafa H; Vanden Bempt I
    J Mol Diagn; 2024 May; 26(5):374-386. PubMed ID: 38395407
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cas9-directed long-read sequencing to resolve optical genome mapping findings in leukemia diagnostics.
    de Boer EN; Vroom V; Scheper AJ; Johansson LF; Bosscher L; Rietema N; Commandeur-Jan SZ; Knoers NVAM; Sikkema-Raddatz B; van den Berg E; van Diemen CC
    Sci Rep; 2024 Apr; 14(1):8508. PubMed ID: 38605095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prenatal diagnosis and molecular cytogenetic characterization of fetuses with central nervous system anomalies using chromosomal microarray analysis: a seven-year single-center retrospective study.
    Zhuang J; Zhang N; Chen Y; Jiang Y; Chen X; Chen W; Chen C
    Sci Rep; 2024 Jan; 14(1):2271. PubMed ID: 38280885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.